- Home
- CZNC vs ABSI Comparison
CZNC vs ABSI Comparison
Compare CZNC & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CZNC | ABSI |
|---|---|---|
| Founded | 1864 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 360.7M | 577.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | CZNC | ABSI |
|---|---|---|
| Price | $19.93 | $3.62 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $22.00 | $7.98 |
| AVG Volume (30 Days) | 78.6K | ★ 3.8M |
| Earning Date | 01-22-2026 | 11-12-2025 |
| Dividend Yield | ★ 5.55% | N/A |
| EPS Growth | ★ 22.09 | N/A |
| EPS | ★ 1.75 | N/A |
| Revenue | ★ $109,632,000.00 | $2,815,000.00 |
| Revenue This Year | $5.72 | $10.72 |
| Revenue Next Year | $7.18 | $437.79 |
| P/E Ratio | $11.51 | ★ N/A |
| Revenue Growth | ★ 7.59 | N/A |
| 52 Week Low | $17.85 | $2.01 |
| 52 Week High | $22.68 | $6.33 |
Technical Indicators
Market Signals| Indicator | CZNC | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 38.05 | 54.08 |
| Support Level | $20.46 | $3.40 |
| Resistance Level | $22.25 | $3.79 |
| Average True Range (ATR) | 0.49 | 0.22 |
| MACD | -0.21 | 0.00 |
| Stochastic Oscillator | 4.92 | 55.73 |
Price Performance
Historical ComparisonAbout CZNC Citizens & Northern Corp
Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.